This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Patnaik, A. K. Articles by Bergman, P. J. Search for Related Content PubMed PubMed Citation Articles by Patnaik, A. K. Articles by Bergman, P. J.

Canine Hepatic Neuroendocrine Carcinoma: An Immunohistochemical and Electron Microscopic Study

Department of Pathology, The Animal Medical Center, New York, NY (AKP, SJN); Animal Health Trust, Lanwades Park, Suffolk, UK (TS); Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY (RAE, CA); and Flaherty Comparative Oncology Laboratory, The Animal Medical Center, New York, NY (DC, PJB)

Ten dogs with neuroendocrine carcinoma of the liver were selected for inclusion in the study. Clinical signs were anorexia (7), vomiting (5), polydipsia/polyuria (3), icterus (2), lethargy (2), weight loss (2), paresis (1), ataxia (1), weakness (1), collapse (1), and urinary tract infection (1). Hematologic and biochemical abnormalities included anemia (2/8), leukocytosis (4/8), high liver enzyme activity (serum alkaline phosphatase, 7/9; alanine transaminase, 7/9; aspartate transaminase, 8/9), and high total bilirubin (6/9). Grossly, the tumors were diffuse, involving all liver lobes in six dogs, and two dogs had various-sized nodules in addition to diffuse involvement. Histologically, there were eight tumors with solid or trabecular pattern (group A), one tumor with cords or rows of neoplastic cells (group B), and one tumor with multiple rosette-like structures (group C). Immunohistochemical studies revealed that all 10 neoplasms were positive for at least one of the endocrine markers used: neuron-specific enolase (NSE; 8/10), synaptophysin (5/10), and chromogranin-A (3/10). A panel of NSE, chromagranin-A, and synaptophysin detected 100% of the tumors in our series. Electron microscopy confirmed the diagnosis by the presence of intracytoplasmic neurosecretory granules in the two examined cases. Our results show that neuroendocrine markers commonly used in humans can be used for the diagnosis of hepatic neuroendocrine carcinoma in dogs, preferably a panel of synaptophysin, chromagranin-A, and NSE because chromogranin-A alone is not as useful in dogs as in humans.

Key words: Canine; electron microscopy; immunohistochemistry; liver; neuroendocrine carcinoma.

Request reprints from Dr. Shelley Newman, Department of Pathology, College of Veterinary Medicine, University of Tennessee, 2407 River Dr, Room A201, Knoxville, TN, 37996-4542 (USA). E-mail: snewman4{at}utk.edu

This article has been cited by other articles:

				F. Ninomiya, S. Suzuki, H. Tanaka, S. Hayashi, K. Ozaki, and I. Narama Nasal and Paranasal Adenocarcinomas with Neuroendocrine Differentiation in Dogs Vet. Pathol., March 1, 2008; 45(2): 181 - 187. [Abstract] [Full Text] [PDF]

				P. Ferreira-Neves, S. Lezmi, T. Lejeune, F. Rakotovao, C. Dally, J.-J. Fontaine, F. Bernex, and N. Cordonnier Immunohistochemical characterization of a hepatic neuroendocrine carcinoma in a cat J Vet Diagn Invest, January 1, 2008; 20(1): 110 - 114. [Abstract] [Full Text] [PDF]